Table 1 Baseline values of the study subjects are given as median and minimum and maximum
From: The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
Groups | Control | Levosimendan | Dobutamine | Dobutamine+Levosimendan |
|---|---|---|---|---|
Weight (g) | 286 (260-313) | 219 (268-336) | 292 (269-338) | 295 (255-315) |
Heart rate/minute | 348 (238-427) | 349 (309-400) | 381 (230-456) | 343 (233-481) |
Systolic blood pressure (mmHg) | 113 (105-129) | 122 (105-131) | 112 (94-150) | 117 (96-134) |
Diastolic blood pressure (mmHg) | 67 (52-86) | 78 (54-86) | 72 (48-100) | 65 (45-87) |
Mean blood pressure (mmHg) | 82 (70-100) | 93 (71-101) | 81 (63-116) | 84 (67-97) |
QRS width (s) | 0.023 (0.022-0.025) | 0.022 (0.019-0.026) | 0.022 (0.019-0.026) | 0.023 (0.020-0.026) |
Arterial blood pH | 7.33 (7.14-7.39) | 7.31 (7.23-7.42) | 7.36 (7.21-7.38) | 7.34 (7.24-7.39) |
Arterial blood pO2 (mmHg) | 182 (118-216) | 148 (105-219) | 153 (128-288) | 149 (118-288) |
Arterial bood pCO2 (mmHg) | 30 (21-39) | 29 (28-38) | 30 (26-38) | 33 (24-42) |